Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44
Using unique computer-assisted 3D reconstruction software, it was previously demonstrated that tumorigenic cell lines derived from breast tumors, when seeded in a 3D Matrigel model, grew as clonal aggregates which, after approximately 100 hours, underwent coalescence mediated by specialized cells, e...
Gespeichert in:
Veröffentlicht in: | PloS one 2017-03, Vol.12 (3), p.e0173400-e0173400 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0173400 |
---|---|
container_issue | 3 |
container_start_page | e0173400 |
container_title | PloS one |
container_volume | 12 |
creator | Wessels, Deborah Lusche, Daniel F Voss, Edward Kuhl, Spencer Buchele, Emma C Klemme, Michael R Russell, Kanoe B Ambrose, Joseph Soll, Benjamin A Bossler, Aaron Milhem, Mohammed Goldman, Charles Soll, David R |
description | Using unique computer-assisted 3D reconstruction software, it was previously demonstrated that tumorigenic cell lines derived from breast tumors, when seeded in a 3D Matrigel model, grew as clonal aggregates which, after approximately 100 hours, underwent coalescence mediated by specialized cells, eventually forming a highly structured large spheroid. Non-tumorigenic cells did not undergo coalescence. Because histological sections of melanomas forming in patients suggest that melanoma cells migrate and coalesce to form tumors, we tested whether they also underwent coalescence in a 3D Matrigel model. Melanoma cells exiting fragments of three independent melanomas or from secondary cultures derived from them, and cells from the melanoma line HTB-66, all underwent coalescence mediated by specialized cells in the 3D model. Normal melanocytes did not. However, coalescence of melanoma cells differed from that of breast-derived tumorigenic cell lines in that they 1) coalesced immediately, 2) underwent coalescence as individual cells as well as aggregates, 3) underwent coalescence far faster and 4) ultimately formed long, flat, fenestrated aggregates that were extremely dynamic. A screen of 51 purified monoclonal antibodies (mAbs) targeting cell surface-associated molecules revealed that two mAbs, anti-beta 1 integrin/(CD29) and anti-CD44, blocked melanoma cell coalescence. They also blocked coalescence of tumorigenic cells derived from a breast tumor. These results add weight to the commonality of coalescence as a characteristic of tumorigenic cells, as well as the usefulness of the 3D Matrigel model and software for both investigating the mechanisms regulating tumorigenesis and screening for potential anti-tumorigenesis mAbs. |
doi_str_mv | 10.1371/journal.pone.0173400 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1874721050</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A484264590</galeid><doaj_id>oai_doaj_org_article_6d777a850b8641f88679938c708d805f</doaj_id><sourcerecordid>A484264590</sourcerecordid><originalsourceid>FETCH-LOGICAL-c655t-b7c591307fbc768837c973d2e4e2d96e5f5c3cc257c12dcbfd493f73630fcc8b3</originalsourceid><addsrcrecordid>eNqNk9tq3DAQhk1padK0b1BaQaG0F7vV0ZJvCmHTw0JCoKdbIcuyV4ttbSQ5NG9fOeuEdclFEEhi9P2_xIwmy14juESEo09bN_hetcud680SIk4ohE-yY1QQvMgxJE8P9kfZixC2EDIi8vx5doQFzinE-XGmL0yretcpoE3bBjD0lfGNA6ppvAnBXhugnWpN0KbXBtgeKEDOwIWK3jamBZ2r0hw3KgIbgDe7UWUqUN4A1Ue7WJ1R-jJ7Vqs2mFfTepL9_vrl1-r74vzy23p1er7QOWNxUXLNCkQgr0vNcyEI1wUnFTbU4KrIDauZJlpjxjXClS7rihak5iQnsNZalOQke7v33bUuyCk_QSLBKccIMpiI9Z6onNrKnbed8jfSKStvA843UvlodWtkXnHOlWCwFDlFtRA5LwoiNIeiEpDVyevzdNtQdqZK-YletTPT-UlvN7Jx15IRktxwMvgwGXh3NZgQZWfDWAXVGzfcvpsLytLyGJQhiggmCX33H_pwIiaqSbWVtq9deqIeTeUpFTT9DlaM1PIBKo3KdFanf1fbFJ8JPs4EiYnmb2zUEIJc__zxePbyz5x9f8BujGrjJrh2iNb1YQ7SPai9C8Gb-r4eCMqxbe6yIce2kVPbJNmbw1rei-76hPwDBN4P9w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1874721050</pqid></control><display><type>article</type><title>Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Wessels, Deborah ; Lusche, Daniel F ; Voss, Edward ; Kuhl, Spencer ; Buchele, Emma C ; Klemme, Michael R ; Russell, Kanoe B ; Ambrose, Joseph ; Soll, Benjamin A ; Bossler, Aaron ; Milhem, Mohammed ; Goldman, Charles ; Soll, David R</creator><contributor>Slominski, Andrzej T.</contributor><creatorcontrib>Wessels, Deborah ; Lusche, Daniel F ; Voss, Edward ; Kuhl, Spencer ; Buchele, Emma C ; Klemme, Michael R ; Russell, Kanoe B ; Ambrose, Joseph ; Soll, Benjamin A ; Bossler, Aaron ; Milhem, Mohammed ; Goldman, Charles ; Soll, David R ; Slominski, Andrzej T.</creatorcontrib><description>Using unique computer-assisted 3D reconstruction software, it was previously demonstrated that tumorigenic cell lines derived from breast tumors, when seeded in a 3D Matrigel model, grew as clonal aggregates which, after approximately 100 hours, underwent coalescence mediated by specialized cells, eventually forming a highly structured large spheroid. Non-tumorigenic cells did not undergo coalescence. Because histological sections of melanomas forming in patients suggest that melanoma cells migrate and coalesce to form tumors, we tested whether they also underwent coalescence in a 3D Matrigel model. Melanoma cells exiting fragments of three independent melanomas or from secondary cultures derived from them, and cells from the melanoma line HTB-66, all underwent coalescence mediated by specialized cells in the 3D model. Normal melanocytes did not. However, coalescence of melanoma cells differed from that of breast-derived tumorigenic cell lines in that they 1) coalesced immediately, 2) underwent coalescence as individual cells as well as aggregates, 3) underwent coalescence far faster and 4) ultimately formed long, flat, fenestrated aggregates that were extremely dynamic. A screen of 51 purified monoclonal antibodies (mAbs) targeting cell surface-associated molecules revealed that two mAbs, anti-beta 1 integrin/(CD29) and anti-CD44, blocked melanoma cell coalescence. They also blocked coalescence of tumorigenic cells derived from a breast tumor. These results add weight to the commonality of coalescence as a characteristic of tumorigenic cells, as well as the usefulness of the 3D Matrigel model and software for both investigating the mechanisms regulating tumorigenesis and screening for potential anti-tumorigenesis mAbs.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0173400</identifier><identifier>PMID: 28264026</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Aggregates ; Antibodies, Monoclonal - pharmacology ; Biology ; Biology and Life Sciences ; Biomarkers ; Biotechnology ; Breast ; Breast cancer ; Cancer cells ; CD29 antigen ; CD44 antigen ; Cell Adhesion ; Cell Line ; Cell migration ; Cell surface ; Cell Tracking ; Coalescence ; Coalescing ; Collagen ; Commonality ; Computer programs ; Dosage and administration ; Drug Combinations ; Forming ; Genetic aspects ; Humans ; Hyaluronan Receptors - metabolism ; Integrin beta1 - metabolism ; Laminin ; Medicine and Health Sciences ; Melanocytes ; Melanocytes - metabolism ; Melanoma ; Melanoma - metabolism ; Melanoma - pathology ; Metastasis ; Microscopy ; Monoclonal antibodies ; Phenotype ; Proteoglycans ; Research and Analysis Methods ; Spheroids, Cellular ; Studies ; Three dimensional models ; Tumor Cells, Cultured ; Tumorigenesis ; Tumors</subject><ispartof>PloS one, 2017-03, Vol.12 (3), p.e0173400-e0173400</ispartof><rights>COPYRIGHT 2017 Public Library of Science</rights><rights>2017 Wessels et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2017 Wessels et al 2017 Wessels et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c655t-b7c591307fbc768837c973d2e4e2d96e5f5c3cc257c12dcbfd493f73630fcc8b3</citedby><cites>FETCH-LOGICAL-c655t-b7c591307fbc768837c973d2e4e2d96e5f5c3cc257c12dcbfd493f73630fcc8b3</cites><orcidid>0000-0002-5059-0315</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338862/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338862/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28264026$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Slominski, Andrzej T.</contributor><creatorcontrib>Wessels, Deborah</creatorcontrib><creatorcontrib>Lusche, Daniel F</creatorcontrib><creatorcontrib>Voss, Edward</creatorcontrib><creatorcontrib>Kuhl, Spencer</creatorcontrib><creatorcontrib>Buchele, Emma C</creatorcontrib><creatorcontrib>Klemme, Michael R</creatorcontrib><creatorcontrib>Russell, Kanoe B</creatorcontrib><creatorcontrib>Ambrose, Joseph</creatorcontrib><creatorcontrib>Soll, Benjamin A</creatorcontrib><creatorcontrib>Bossler, Aaron</creatorcontrib><creatorcontrib>Milhem, Mohammed</creatorcontrib><creatorcontrib>Goldman, Charles</creatorcontrib><creatorcontrib>Soll, David R</creatorcontrib><title>Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Using unique computer-assisted 3D reconstruction software, it was previously demonstrated that tumorigenic cell lines derived from breast tumors, when seeded in a 3D Matrigel model, grew as clonal aggregates which, after approximately 100 hours, underwent coalescence mediated by specialized cells, eventually forming a highly structured large spheroid. Non-tumorigenic cells did not undergo coalescence. Because histological sections of melanomas forming in patients suggest that melanoma cells migrate and coalesce to form tumors, we tested whether they also underwent coalescence in a 3D Matrigel model. Melanoma cells exiting fragments of three independent melanomas or from secondary cultures derived from them, and cells from the melanoma line HTB-66, all underwent coalescence mediated by specialized cells in the 3D model. Normal melanocytes did not. However, coalescence of melanoma cells differed from that of breast-derived tumorigenic cell lines in that they 1) coalesced immediately, 2) underwent coalescence as individual cells as well as aggregates, 3) underwent coalescence far faster and 4) ultimately formed long, flat, fenestrated aggregates that were extremely dynamic. A screen of 51 purified monoclonal antibodies (mAbs) targeting cell surface-associated molecules revealed that two mAbs, anti-beta 1 integrin/(CD29) and anti-CD44, blocked melanoma cell coalescence. They also blocked coalescence of tumorigenic cells derived from a breast tumor. These results add weight to the commonality of coalescence as a characteristic of tumorigenic cells, as well as the usefulness of the 3D Matrigel model and software for both investigating the mechanisms regulating tumorigenesis and screening for potential anti-tumorigenesis mAbs.</description><subject>Aggregates</subject><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Biology</subject><subject>Biology and Life Sciences</subject><subject>Biomarkers</subject><subject>Biotechnology</subject><subject>Breast</subject><subject>Breast cancer</subject><subject>Cancer cells</subject><subject>CD29 antigen</subject><subject>CD44 antigen</subject><subject>Cell Adhesion</subject><subject>Cell Line</subject><subject>Cell migration</subject><subject>Cell surface</subject><subject>Cell Tracking</subject><subject>Coalescence</subject><subject>Coalescing</subject><subject>Collagen</subject><subject>Commonality</subject><subject>Computer programs</subject><subject>Dosage and administration</subject><subject>Drug Combinations</subject><subject>Forming</subject><subject>Genetic aspects</subject><subject>Humans</subject><subject>Hyaluronan Receptors - metabolism</subject><subject>Integrin beta1 - metabolism</subject><subject>Laminin</subject><subject>Medicine and Health Sciences</subject><subject>Melanocytes</subject><subject>Melanocytes - metabolism</subject><subject>Melanoma</subject><subject>Melanoma - metabolism</subject><subject>Melanoma - pathology</subject><subject>Metastasis</subject><subject>Microscopy</subject><subject>Monoclonal antibodies</subject><subject>Phenotype</subject><subject>Proteoglycans</subject><subject>Research and Analysis Methods</subject><subject>Spheroids, Cellular</subject><subject>Studies</subject><subject>Three dimensional models</subject><subject>Tumor Cells, Cultured</subject><subject>Tumorigenesis</subject><subject>Tumors</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk9tq3DAQhk1padK0b1BaQaG0F7vV0ZJvCmHTw0JCoKdbIcuyV4ttbSQ5NG9fOeuEdclFEEhi9P2_xIwmy14juESEo09bN_hetcud680SIk4ohE-yY1QQvMgxJE8P9kfZixC2EDIi8vx5doQFzinE-XGmL0yretcpoE3bBjD0lfGNA6ppvAnBXhugnWpN0KbXBtgeKEDOwIWK3jamBZ2r0hw3KgIbgDe7UWUqUN4A1Ue7WJ1R-jJ7Vqs2mFfTepL9_vrl1-r74vzy23p1er7QOWNxUXLNCkQgr0vNcyEI1wUnFTbU4KrIDauZJlpjxjXClS7rihak5iQnsNZalOQke7v33bUuyCk_QSLBKccIMpiI9Z6onNrKnbed8jfSKStvA843UvlodWtkXnHOlWCwFDlFtRA5LwoiNIeiEpDVyevzdNtQdqZK-YletTPT-UlvN7Jx15IRktxwMvgwGXh3NZgQZWfDWAXVGzfcvpsLytLyGJQhiggmCX33H_pwIiaqSbWVtq9deqIeTeUpFTT9DlaM1PIBKo3KdFanf1fbFJ8JPs4EiYnmb2zUEIJc__zxePbyz5x9f8BujGrjJrh2iNb1YQ7SPai9C8Gb-r4eCMqxbe6yIce2kVPbJNmbw1rei-76hPwDBN4P9w</recordid><startdate>20170306</startdate><enddate>20170306</enddate><creator>Wessels, Deborah</creator><creator>Lusche, Daniel F</creator><creator>Voss, Edward</creator><creator>Kuhl, Spencer</creator><creator>Buchele, Emma C</creator><creator>Klemme, Michael R</creator><creator>Russell, Kanoe B</creator><creator>Ambrose, Joseph</creator><creator>Soll, Benjamin A</creator><creator>Bossler, Aaron</creator><creator>Milhem, Mohammed</creator><creator>Goldman, Charles</creator><creator>Soll, David R</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-5059-0315</orcidid></search><sort><creationdate>20170306</creationdate><title>Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44</title><author>Wessels, Deborah ; Lusche, Daniel F ; Voss, Edward ; Kuhl, Spencer ; Buchele, Emma C ; Klemme, Michael R ; Russell, Kanoe B ; Ambrose, Joseph ; Soll, Benjamin A ; Bossler, Aaron ; Milhem, Mohammed ; Goldman, Charles ; Soll, David R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c655t-b7c591307fbc768837c973d2e4e2d96e5f5c3cc257c12dcbfd493f73630fcc8b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aggregates</topic><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Biology</topic><topic>Biology and Life Sciences</topic><topic>Biomarkers</topic><topic>Biotechnology</topic><topic>Breast</topic><topic>Breast cancer</topic><topic>Cancer cells</topic><topic>CD29 antigen</topic><topic>CD44 antigen</topic><topic>Cell Adhesion</topic><topic>Cell Line</topic><topic>Cell migration</topic><topic>Cell surface</topic><topic>Cell Tracking</topic><topic>Coalescence</topic><topic>Coalescing</topic><topic>Collagen</topic><topic>Commonality</topic><topic>Computer programs</topic><topic>Dosage and administration</topic><topic>Drug Combinations</topic><topic>Forming</topic><topic>Genetic aspects</topic><topic>Humans</topic><topic>Hyaluronan Receptors - metabolism</topic><topic>Integrin beta1 - metabolism</topic><topic>Laminin</topic><topic>Medicine and Health Sciences</topic><topic>Melanocytes</topic><topic>Melanocytes - metabolism</topic><topic>Melanoma</topic><topic>Melanoma - metabolism</topic><topic>Melanoma - pathology</topic><topic>Metastasis</topic><topic>Microscopy</topic><topic>Monoclonal antibodies</topic><topic>Phenotype</topic><topic>Proteoglycans</topic><topic>Research and Analysis Methods</topic><topic>Spheroids, Cellular</topic><topic>Studies</topic><topic>Three dimensional models</topic><topic>Tumor Cells, Cultured</topic><topic>Tumorigenesis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wessels, Deborah</creatorcontrib><creatorcontrib>Lusche, Daniel F</creatorcontrib><creatorcontrib>Voss, Edward</creatorcontrib><creatorcontrib>Kuhl, Spencer</creatorcontrib><creatorcontrib>Buchele, Emma C</creatorcontrib><creatorcontrib>Klemme, Michael R</creatorcontrib><creatorcontrib>Russell, Kanoe B</creatorcontrib><creatorcontrib>Ambrose, Joseph</creatorcontrib><creatorcontrib>Soll, Benjamin A</creatorcontrib><creatorcontrib>Bossler, Aaron</creatorcontrib><creatorcontrib>Milhem, Mohammed</creatorcontrib><creatorcontrib>Goldman, Charles</creatorcontrib><creatorcontrib>Soll, David R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wessels, Deborah</au><au>Lusche, Daniel F</au><au>Voss, Edward</au><au>Kuhl, Spencer</au><au>Buchele, Emma C</au><au>Klemme, Michael R</au><au>Russell, Kanoe B</au><au>Ambrose, Joseph</au><au>Soll, Benjamin A</au><au>Bossler, Aaron</au><au>Milhem, Mohammed</au><au>Goldman, Charles</au><au>Soll, David R</au><au>Slominski, Andrzej T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2017-03-06</date><risdate>2017</risdate><volume>12</volume><issue>3</issue><spage>e0173400</spage><epage>e0173400</epage><pages>e0173400-e0173400</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Using unique computer-assisted 3D reconstruction software, it was previously demonstrated that tumorigenic cell lines derived from breast tumors, when seeded in a 3D Matrigel model, grew as clonal aggregates which, after approximately 100 hours, underwent coalescence mediated by specialized cells, eventually forming a highly structured large spheroid. Non-tumorigenic cells did not undergo coalescence. Because histological sections of melanomas forming in patients suggest that melanoma cells migrate and coalesce to form tumors, we tested whether they also underwent coalescence in a 3D Matrigel model. Melanoma cells exiting fragments of three independent melanomas or from secondary cultures derived from them, and cells from the melanoma line HTB-66, all underwent coalescence mediated by specialized cells in the 3D model. Normal melanocytes did not. However, coalescence of melanoma cells differed from that of breast-derived tumorigenic cell lines in that they 1) coalesced immediately, 2) underwent coalescence as individual cells as well as aggregates, 3) underwent coalescence far faster and 4) ultimately formed long, flat, fenestrated aggregates that were extremely dynamic. A screen of 51 purified monoclonal antibodies (mAbs) targeting cell surface-associated molecules revealed that two mAbs, anti-beta 1 integrin/(CD29) and anti-CD44, blocked melanoma cell coalescence. They also blocked coalescence of tumorigenic cells derived from a breast tumor. These results add weight to the commonality of coalescence as a characteristic of tumorigenic cells, as well as the usefulness of the 3D Matrigel model and software for both investigating the mechanisms regulating tumorigenesis and screening for potential anti-tumorigenesis mAbs.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>28264026</pmid><doi>10.1371/journal.pone.0173400</doi><orcidid>https://orcid.org/0000-0002-5059-0315</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2017-03, Vol.12 (3), p.e0173400-e0173400 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1874721050 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Aggregates Antibodies, Monoclonal - pharmacology Biology Biology and Life Sciences Biomarkers Biotechnology Breast Breast cancer Cancer cells CD29 antigen CD44 antigen Cell Adhesion Cell Line Cell migration Cell surface Cell Tracking Coalescence Coalescing Collagen Commonality Computer programs Dosage and administration Drug Combinations Forming Genetic aspects Humans Hyaluronan Receptors - metabolism Integrin beta1 - metabolism Laminin Medicine and Health Sciences Melanocytes Melanocytes - metabolism Melanoma Melanoma - metabolism Melanoma - pathology Metastasis Microscopy Monoclonal antibodies Phenotype Proteoglycans Research and Analysis Methods Spheroids, Cellular Studies Three dimensional models Tumor Cells, Cultured Tumorigenesis Tumors |
title | Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T09%3A08%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Melanoma%20cells%20undergo%20aggressive%20coalescence%20in%20a%203D%20Matrigel%20model%20that%20is%20repressed%20by%20anti-CD44&rft.jtitle=PloS%20one&rft.au=Wessels,%20Deborah&rft.date=2017-03-06&rft.volume=12&rft.issue=3&rft.spage=e0173400&rft.epage=e0173400&rft.pages=e0173400-e0173400&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0173400&rft_dat=%3Cgale_plos_%3EA484264590%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1874721050&rft_id=info:pmid/28264026&rft_galeid=A484264590&rft_doaj_id=oai_doaj_org_article_6d777a850b8641f88679938c708d805f&rfr_iscdi=true |